> top > docs > PubMed:17166870 > annotations

PubMed:17166870 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCoin-sentences

Id Subject Object Predicate Lexical cue
T1 0-113 Sentence denotes Association between an endoglin gene polymorphism and systemic sclerosis-related pulmonary arterial hypertension.
T2 114-125 Sentence denotes UNLABELLED:
T3 126-262 Sentence denotes Systemic sclerosis (SSc) is a connective tissue disorder characterized by early generalized microangiopathy with disturbed angiogenesis.
T4 263-470 Sentence denotes Endoglin gene (ENG) encodes a transmembrane glycoprotein which acts as an accessory receptor for the transforming growth factor-beta (TGF-beta) superfamily, and is crucial for maintaining vascular integrity.
T5 471-583 Sentence denotes A 6-base insertion in intron 7 (6bINS) of ENG has been reported to be associated with microvascular disturbance.
T6 584-595 Sentence denotes OBJECTIVES:
T7 596-768 Sentence denotes Our objective was to investigate the relationship between 6bINS and the vascular complication pulmonary arterial hypertension (PAH) in SSc in a French Caucasian population.
T8 769-777 Sentence denotes METHODS:
T9 778-913 Sentence denotes Two hundred eighty SSc cases containing 29/280 having PAH diagnosed by catheterism were compared with 140 patients with osteoarthritis.
T10 914-1024 Sentence denotes Genotyping was performed by polymerase-chain-reaction-based fluorescence and direct sequencing of genomic DNA.
T11 1025-1033 Sentence denotes RESULTS:
T12 1034-1085 Sentence denotes The polymorphism was in Hardy-Weinberg equilibrium.
T13 1086-1377 Sentence denotes We observed a significant lower frequency of 6bINS allele in SSc patients with associated PAH compared with controls [10.3 vs 23.9%, P = 0.01; odds ratio (OR) 0.37, 95% confidence interval (CI) 0.15-0.89], and a trend in comparison with SSc patients without PAH (10.3 vs 20.3%, P = 0.05; OR:
T14 1378-1391 Sentence denotes 0.45, 95% CI:
T15 1392-1403 Sentence denotes 0.19-1.08).
T16 1404-1528 Sentence denotes Genotypes carrying allele 6bINS were also less frequent in SSc patients with PAH than in controls (20.7 vs 42.9%, P = 0.02).
T17 1529-1541 Sentence denotes CONCLUSIONS:
T18 1542-1703 Sentence denotes Thus the frequency of 6bINS differs between SSc patients with or without PAH, suggesting the implication of ENG in this devastating vascular complication of SSc.

LitCoin-entities

Id Subject Object Predicate Lexical cue db_id
3693 23-31 GeneOrGeneProduct denotes endoglin NCBIGene:2022
3694 54-72 DiseaseOrPhenotypicFeature denotes systemic sclerosis MESH:D012595
3695 81-112 DiseaseOrPhenotypicFeature denotes pulmonary arterial hypertension MESH:D000081029
3696 126-144 DiseaseOrPhenotypicFeature denotes Systemic sclerosis MESH:D012595
3697 146-149 DiseaseOrPhenotypicFeature denotes SSc MESH:D012595
3698 218-233 DiseaseOrPhenotypicFeature denotes microangiopathy MESH:D057049
3699 263-271 GeneOrGeneProduct denotes Endoglin NCBIGene:2022
3700 278-281 GeneOrGeneProduct denotes ENG NCBIGene:2022
3701 307-319 GeneOrGeneProduct denotes glycoprotein NCBIGene:351
3702 364-395 GeneOrGeneProduct denotes transforming growth factor-beta NCBIGene:7040
3703 397-405 GeneOrGeneProduct denotes TGF-beta NCBIGene:7040
3704 473-489 SequenceVariant denotes 6-base insertion c|INS||6
3705 503-508 SequenceVariant denotes 6bINS c|INS||6
3706 513-516 GeneOrGeneProduct denotes ENG NCBIGene:2022
3707 654-659 SequenceVariant denotes 6bINS c|INS||6
3708 668-689 DiseaseOrPhenotypicFeature denotes vascular complication MESH:D014652
3709 690-721 DiseaseOrPhenotypicFeature denotes pulmonary arterial hypertension MESH:D000081029
3710 723-726 DiseaseOrPhenotypicFeature denotes PAH MESH:D000081029
3711 731-734 DiseaseOrPhenotypicFeature denotes SSc MESH:D012595
3712 797-800 DiseaseOrPhenotypicFeature denotes SSc MESH:D012595
3713 832-835 DiseaseOrPhenotypicFeature denotes PAH MESH:D000081029
3714 884-892 OrganismTaxon denotes patients NCBITaxon:9606
3715 898-912 DiseaseOrPhenotypicFeature denotes osteoarthritis MESH:D010003
3716 1131-1136 SequenceVariant denotes 6bINS c|INS||6
3717 1147-1150 DiseaseOrPhenotypicFeature denotes SSc MESH:D012595
3718 1151-1159 OrganismTaxon denotes patients NCBITaxon:9606
3719 1176-1179 DiseaseOrPhenotypicFeature denotes PAH MESH:D000081029
3720 1323-1326 DiseaseOrPhenotypicFeature denotes SSc MESH:D012595
3721 1327-1335 OrganismTaxon denotes patients NCBITaxon:9606
3722 1344-1347 DiseaseOrPhenotypicFeature denotes PAH MESH:D000081029
3723 1430-1435 SequenceVariant denotes 6bINS c|INS||6
3724 1463-1466 DiseaseOrPhenotypicFeature denotes SSc MESH:D012595
3725 1467-1475 OrganismTaxon denotes patients NCBITaxon:9606
3726 1481-1484 DiseaseOrPhenotypicFeature denotes PAH MESH:D000081029
3727 1564-1569 SequenceVariant denotes 6bINS c|INS||6
3728 1586-1589 DiseaseOrPhenotypicFeature denotes SSc MESH:D012595
3729 1590-1598 OrganismTaxon denotes patients NCBITaxon:9606
3730 1615-1618 DiseaseOrPhenotypicFeature denotes PAH MESH:D000081029
3731 1650-1653 GeneOrGeneProduct denotes ENG NCBIGene:2022
3732 1674-1695 DiseaseOrPhenotypicFeature denotes vascular complication MESH:D014652
3733 1699-1702 DiseaseOrPhenotypicFeature denotes SSc MESH:D012595

LitCoin_Mondo

Id Subject Object Predicate Lexical cue mondo_id
T1 54-72 DiseaseOrPhenotypicFeature denotes systemic sclerosis 0005100
T2 81-112 DiseaseOrPhenotypicFeature denotes pulmonary arterial hypertension 0015924
T3 126-144 DiseaseOrPhenotypicFeature denotes Systemic sclerosis 0005100
T4 690-721 DiseaseOrPhenotypicFeature denotes pulmonary arterial hypertension 0015924
T5 898-912 DiseaseOrPhenotypicFeature denotes osteoarthritis 0005178

LitCoin-SeqVar

Id Subject Object Predicate Lexical cue
T1 503-508 SequenceVariant denotes 6bINS
T2 654-659 SequenceVariant denotes 6bINS
T3 1131-1136 SequenceVariant denotes 6bINS
T4 1430-1435 SequenceVariant denotes 6bINS
T5 1564-1569 SequenceVariant denotes 6bINS

LitCoin-GeneOrGeneProduct-v2

Id Subject Object Predicate Lexical cue
T1 23-31 GeneOrGeneProduct denotes endoglin
T2 100-112 GeneOrGeneProduct denotes hypertension
T3 200-205 GeneOrGeneProduct denotes early
T4 263-271 GeneOrGeneProduct denotes Endoglin
T5 293-319 GeneOrGeneProduct denotes transmembrane glycoprotein
T6 347-355 GeneOrGeneProduct denotes receptor
T7 364-395 GeneOrGeneProduct denotes transforming growth factor-beta
T8 397-405 GeneOrGeneProduct denotes TGF-beta
T9 709-721 GeneOrGeneProduct denotes hypertension
T10 942-952 GeneOrGeneProduct denotes polymerase
T11 953-958 GeneOrGeneProduct denotes chain
T12 1118-1127 GeneOrGeneProduct denotes frequency
T13 1551-1560 GeneOrGeneProduct denotes frequency

LitCoin-GeneOrGeneProduct-v0

Id Subject Object Predicate Lexical cue
T1 23-31 GeneOrGeneProduct denotes endoglin
T2 100-112 GeneOrGeneProduct denotes hypertension
T3 145-155 GeneOrGeneProduct denotes (SSc) is a
T4 200-205 GeneOrGeneProduct denotes early
T5 263-271 GeneOrGeneProduct denotes Endoglin
T6 293-319 GeneOrGeneProduct denotes transmembrane glycoprotein
T7 326-330 GeneOrGeneProduct denotes acts
T8 347-355 GeneOrGeneProduct denotes receptor
T9 364-395 GeneOrGeneProduct denotes transforming growth factor-beta
T10 397-405 GeneOrGeneProduct denotes TGF-beta
T11 475-479 GeneOrGeneProduct denotes base
T12 709-721 GeneOrGeneProduct denotes hypertension
T13 735-739 GeneOrGeneProduct denotes in a
T14 769-776 GeneOrGeneProduct denotes METHODS
T15 801-806 GeneOrGeneProduct denotes cases
T16 942-952 GeneOrGeneProduct denotes polymerase
T17 953-958 GeneOrGeneProduct denotes chain
T18 968-973 GeneOrGeneProduct denotes based
T19 1058-1063 GeneOrGeneProduct denotes Hardy
T20 1118-1127 GeneOrGeneProduct denotes frequency
T21 1551-1560 GeneOrGeneProduct denotes frequency

LitCoin-Disease-MeSH

Id Subject Object Predicate Lexical cue originalLabel
T1 54-72 DiseaseOrPhenotypicFeature denotes systemic sclerosis D012595
T2 81-112 DiseaseOrPhenotypicFeature denotes pulmonary arterial hypertension D000081029
T3 126-144 DiseaseOrPhenotypicFeature denotes Systemic sclerosis D012595
T4 146-149 DiseaseOrPhenotypicFeature denotes SSc D012595
T5 690-721 DiseaseOrPhenotypicFeature denotes pulmonary arterial hypertension D000081029
T6 723-726 DiseaseOrPhenotypicFeature denotes PAH D000081029
T7 731-734 DiseaseOrPhenotypicFeature denotes SSc D012595
T8 797-800 DiseaseOrPhenotypicFeature denotes SSc D012595
T9 832-835 DiseaseOrPhenotypicFeature denotes PAH D000081029
T10 898-912 DiseaseOrPhenotypicFeature denotes osteoarthritis D010003
T11 1147-1150 DiseaseOrPhenotypicFeature denotes SSc D012595
T12 1176-1179 DiseaseOrPhenotypicFeature denotes PAH D000081029
T13 1323-1326 DiseaseOrPhenotypicFeature denotes SSc D012595
T14 1344-1347 DiseaseOrPhenotypicFeature denotes PAH D000081029
T15 1463-1466 DiseaseOrPhenotypicFeature denotes SSc D012595
T16 1481-1484 DiseaseOrPhenotypicFeature denotes PAH D000081029
T17 1586-1589 DiseaseOrPhenotypicFeature denotes SSc D012595
T18 1615-1618 DiseaseOrPhenotypicFeature denotes PAH D000081029
T19 1699-1702 DiseaseOrPhenotypicFeature denotes SSc D012595

LitCoin-GeneOrGeneProduct-v3

Id Subject Object Predicate Lexical cue
T1 23-31 GeneOrGeneProduct denotes endoglin
T2 263-271 GeneOrGeneProduct denotes Endoglin
T3 293-319 GeneOrGeneProduct denotes transmembrane glycoprotein
T4 364-395 GeneOrGeneProduct denotes transforming growth factor-beta
T5 397-405 GeneOrGeneProduct denotes TGF-beta

LitCoin_Mondo_095

Id Subject Object Predicate Lexical cue mondo_id
T1 54-72 DiseaseOrPhenotypicFeature denotes systemic sclerosis 0005100
T2 81-112 DiseaseOrPhenotypicFeature denotes pulmonary arterial hypertension 0024533|0015924
T4 126-144 DiseaseOrPhenotypicFeature denotes Systemic sclerosis 0005100
T5 146-149 DiseaseOrPhenotypicFeature denotes SSc 0005100
T6 156-182 DiseaseOrPhenotypicFeature denotes connective tissue disorder 0003900
T7 690-721 DiseaseOrPhenotypicFeature denotes pulmonary arterial hypertension 0024533|0015924
T9 723-726 DiseaseOrPhenotypicFeature denotes PAH 0015924|0024533
T11 731-734 DiseaseOrPhenotypicFeature denotes SSc 0005100
T12 797-800 DiseaseOrPhenotypicFeature denotes SSc 0005100
T13 832-835 DiseaseOrPhenotypicFeature denotes PAH 0015924|0024533
T15 898-912 DiseaseOrPhenotypicFeature denotes osteoarthritis 0005178
T16 1147-1150 DiseaseOrPhenotypicFeature denotes SSc 0005100
T17 1176-1179 DiseaseOrPhenotypicFeature denotes PAH 0015924|0024533
T19 1323-1326 DiseaseOrPhenotypicFeature denotes SSc 0005100
T20 1344-1347 DiseaseOrPhenotypicFeature denotes PAH 0015924|0024533
T22 1463-1466 DiseaseOrPhenotypicFeature denotes SSc 0005100
T23 1481-1484 DiseaseOrPhenotypicFeature denotes PAH 0015924|0024533
T25 1586-1589 DiseaseOrPhenotypicFeature denotes SSc 0005100
T26 1615-1618 DiseaseOrPhenotypicFeature denotes PAH 0015924|0024533
T28 1699-1702 DiseaseOrPhenotypicFeature denotes SSc 0005100

LitCoin-MeSH-Disease-2

Id Subject Object Predicate Lexical cue ID:
T1 54-72 DiseaseOrPhenotypicFeature denotes systemic sclerosis D012595
T2 81-112 DiseaseOrPhenotypicFeature denotes pulmonary arterial hypertension D000081029
T3 126-144 DiseaseOrPhenotypicFeature denotes Systemic sclerosis D012595
T4 146-149 DiseaseOrPhenotypicFeature denotes SSc D012595
T5 218-233 DiseaseOrPhenotypicFeature denotes microangiopathy DISEASE
T6 668-689 DiseaseOrPhenotypicFeature denotes vascular complication DISEASE
T7 690-721 DiseaseOrPhenotypicFeature denotes pulmonary arterial hypertension D000081029
T8 723-726 DiseaseOrPhenotypicFeature denotes PAH D000081029
T9 731-734 DiseaseOrPhenotypicFeature denotes SSc D012595
T10 797-800 DiseaseOrPhenotypicFeature denotes SSc D012595
T11 832-835 DiseaseOrPhenotypicFeature denotes PAH D000081029
T12 898-912 DiseaseOrPhenotypicFeature denotes osteoarthritis D010003
T13 1147-1150 DiseaseOrPhenotypicFeature denotes SSc D012595
T14 1176-1179 DiseaseOrPhenotypicFeature denotes PAH D000081029
T15 1323-1326 DiseaseOrPhenotypicFeature denotes SSc D012595
T16 1344-1347 DiseaseOrPhenotypicFeature denotes PAH D000081029
T17 1463-1466 DiseaseOrPhenotypicFeature denotes SSc D012595
T18 1481-1484 DiseaseOrPhenotypicFeature denotes PAH D000081029
T19 1586-1589 DiseaseOrPhenotypicFeature denotes SSc D012595
T20 1615-1618 DiseaseOrPhenotypicFeature denotes PAH D000081029
T21 1674-1695 DiseaseOrPhenotypicFeature denotes vascular complication DISEASE
T22 1699-1702 DiseaseOrPhenotypicFeature denotes SSc D012595

LitCoin-MONDO_bioort2019

Id Subject Object Predicate Lexical cue #label
T1 54-72 DiseaseOrPhenotypicFeature denotes systemic sclerosis D012595
T2 81-112 DiseaseOrPhenotypicFeature denotes pulmonary arterial hypertension D000081029
T3 126-144 DiseaseOrPhenotypicFeature denotes Systemic sclerosis D012595
T4 146-149 DiseaseOrPhenotypicFeature denotes SSc D012595
T5 218-233 DiseaseOrPhenotypicFeature denotes microangiopathy DISEASE
T6 668-689 DiseaseOrPhenotypicFeature denotes vascular complication DISEASE
T7 690-721 DiseaseOrPhenotypicFeature denotes pulmonary arterial hypertension D000081029
T8 723-726 DiseaseOrPhenotypicFeature denotes PAH D000081029
T9 731-734 DiseaseOrPhenotypicFeature denotes SSc D012595
T10 797-800 DiseaseOrPhenotypicFeature denotes SSc D012595
T11 832-835 DiseaseOrPhenotypicFeature denotes PAH D000081029
T12 898-912 DiseaseOrPhenotypicFeature denotes osteoarthritis D010003
T13 1147-1150 DiseaseOrPhenotypicFeature denotes SSc D012595
T14 1176-1179 DiseaseOrPhenotypicFeature denotes PAH D000081029
T15 1323-1326 DiseaseOrPhenotypicFeature denotes SSc D012595
T16 1344-1347 DiseaseOrPhenotypicFeature denotes PAH D000081029
T17 1463-1466 DiseaseOrPhenotypicFeature denotes SSc D012595
T18 1481-1484 DiseaseOrPhenotypicFeature denotes PAH D000081029
T19 1586-1589 DiseaseOrPhenotypicFeature denotes SSc D012595
T20 1615-1618 DiseaseOrPhenotypicFeature denotes PAH D000081029
T21 1674-1695 DiseaseOrPhenotypicFeature denotes vascular complication DISEASE
T22 1699-1702 DiseaseOrPhenotypicFeature denotes SSc D012595

LitCoin-Chemical-MeSH-CHEBI

Id Subject Object Predicate Lexical cue ID:
T1 723-726 ChemicalEntity denotes PAH http://purl.obolibrary.org/obo/CHEBI_53305|http://purl.obolibrary.org/obo/CHEBI_33848|http://purl.obolibrary.org/obo/CHEBI_31204|http://purl.obolibrary.org/obo/CHEBI_104011
T5 832-835 ChemicalEntity denotes PAH http://purl.obolibrary.org/obo/CHEBI_53305|http://purl.obolibrary.org/obo/CHEBI_33848|http://purl.obolibrary.org/obo/CHEBI_31204|http://purl.obolibrary.org/obo/CHEBI_104011
T9 1176-1179 ChemicalEntity denotes PAH http://purl.obolibrary.org/obo/CHEBI_53305|http://purl.obolibrary.org/obo/CHEBI_33848|http://purl.obolibrary.org/obo/CHEBI_31204|http://purl.obolibrary.org/obo/CHEBI_104011
T13 1344-1347 ChemicalEntity denotes PAH http://purl.obolibrary.org/obo/CHEBI_53305|http://purl.obolibrary.org/obo/CHEBI_33848|http://purl.obolibrary.org/obo/CHEBI_31204|http://purl.obolibrary.org/obo/CHEBI_104011
T17 1481-1484 ChemicalEntity denotes PAH http://purl.obolibrary.org/obo/CHEBI_53305|http://purl.obolibrary.org/obo/CHEBI_33848|http://purl.obolibrary.org/obo/CHEBI_31204|http://purl.obolibrary.org/obo/CHEBI_104011
T21 1615-1618 ChemicalEntity denotes PAH http://purl.obolibrary.org/obo/CHEBI_53305|http://purl.obolibrary.org/obo/CHEBI_33848|http://purl.obolibrary.org/obo/CHEBI_31204|http://purl.obolibrary.org/obo/CHEBI_104011

LitCoin-NCBITaxon-2

Id Subject Object Predicate Lexical cue
T1 884-892 OrganismTaxon denotes patients
T2 1151-1159 OrganismTaxon denotes patients
T3 1327-1335 OrganismTaxon denotes patients
T4 1467-1475 OrganismTaxon denotes patients
T5 1590-1598 OrganismTaxon denotes patients

LitCoin-training-merged

Id Subject Object Predicate Lexical cue #label ID:
T21 1615-1618 ChemicalEntity denotes PAH http://purl.obolibrary.org/obo/CHEBI_104011|http://purl.obolibrary.org/obo/CHEBI_31204|http://purl.obolibrary.org/obo/CHEBI_33848|http://purl.obolibrary.org/obo/CHEBI_53305
T17 1481-1484 ChemicalEntity denotes PAH http://purl.obolibrary.org/obo/CHEBI_104011|http://purl.obolibrary.org/obo/CHEBI_31204|http://purl.obolibrary.org/obo/CHEBI_33848|http://purl.obolibrary.org/obo/CHEBI_53305
T13 1344-1347 ChemicalEntity denotes PAH http://purl.obolibrary.org/obo/CHEBI_104011|http://purl.obolibrary.org/obo/CHEBI_31204|http://purl.obolibrary.org/obo/CHEBI_33848|http://purl.obolibrary.org/obo/CHEBI_53305
T9 1176-1179 ChemicalEntity denotes PAH http://purl.obolibrary.org/obo/CHEBI_104011|http://purl.obolibrary.org/obo/CHEBI_31204|http://purl.obolibrary.org/obo/CHEBI_33848|http://purl.obolibrary.org/obo/CHEBI_53305
T5 832-835 ChemicalEntity denotes PAH http://purl.obolibrary.org/obo/CHEBI_104011|http://purl.obolibrary.org/obo/CHEBI_31204|http://purl.obolibrary.org/obo/CHEBI_33848|http://purl.obolibrary.org/obo/CHEBI_53305
T1 723-726 ChemicalEntity denotes PAH http://purl.obolibrary.org/obo/CHEBI_104011|http://purl.obolibrary.org/obo/CHEBI_31204|http://purl.obolibrary.org/obo/CHEBI_33848|http://purl.obolibrary.org/obo/CHEBI_53305
T90565 397-405 GeneOrGeneProduct denotes TGF-beta
T4 364-395 GeneOrGeneProduct denotes transforming growth factor-beta
T3 293-319 GeneOrGeneProduct denotes transmembrane glycoprotein
T2 263-271 GeneOrGeneProduct denotes Endoglin
T3851 23-31 GeneOrGeneProduct denotes endoglin
T22 1699-1702 DiseaseOrPhenotypicFeature denotes SSc D012595
T92818 1674-1695 DiseaseOrPhenotypicFeature denotes vascular complication DISEASE
T20 1615-1618 DiseaseOrPhenotypicFeature denotes PAH D000081029
T19 1586-1589 DiseaseOrPhenotypicFeature denotes SSc D012595
T18 1481-1484 DiseaseOrPhenotypicFeature denotes PAH D000081029
T68731 1463-1466 DiseaseOrPhenotypicFeature denotes SSc D012595
T16 1344-1347 DiseaseOrPhenotypicFeature denotes PAH D000081029
T15 1323-1326 DiseaseOrPhenotypicFeature denotes SSc D012595
T14 1176-1179 DiseaseOrPhenotypicFeature denotes PAH D000081029
T33282 1147-1150 DiseaseOrPhenotypicFeature denotes SSc D012595
T12 898-912 DiseaseOrPhenotypicFeature denotes osteoarthritis D010003
T11 832-835 DiseaseOrPhenotypicFeature denotes PAH D000081029
T10 797-800 DiseaseOrPhenotypicFeature denotes SSc D012595
T86237 731-734 DiseaseOrPhenotypicFeature denotes SSc D012595
T8 723-726 DiseaseOrPhenotypicFeature denotes PAH D000081029
T7 690-721 DiseaseOrPhenotypicFeature denotes pulmonary arterial hypertension D000081029
T6 668-689 DiseaseOrPhenotypicFeature denotes vascular complication DISEASE
T14156 218-233 DiseaseOrPhenotypicFeature denotes microangiopathy DISEASE
T65914 146-149 DiseaseOrPhenotypicFeature denotes SSc D012595
T88367 126-144 DiseaseOrPhenotypicFeature denotes Systemic sclerosis D012595
T96334 81-112 DiseaseOrPhenotypicFeature denotes pulmonary arterial hypertension D000081029
T94954 54-72 DiseaseOrPhenotypicFeature denotes systemic sclerosis D012595
T18725 1590-1598 OrganismTaxon denotes patients
T61043 1467-1475 OrganismTaxon denotes patients
T93461 1327-1335 OrganismTaxon denotes patients
T57119 1151-1159 OrganismTaxon denotes patients
T44649 884-892 OrganismTaxon denotes patients
T97443 1564-1569 SequenceVariant denotes 6bINS
T10156 1430-1435 SequenceVariant denotes 6bINS
T37731 1131-1136 SequenceVariant denotes 6bINS
T75926 654-659 SequenceVariant denotes 6bINS
T78758 503-508 SequenceVariant denotes 6bINS

DisGeNET

Id Subject Object Predicate Lexical cue
T0 23-31 gene:2022 denotes endoglin
T1 54-72 disease:C0036421 denotes systemic sclerosis
T2 23-31 gene:2022 denotes endoglin
T3 81-112 disease:C0152171 denotes pulmonary arterial hypertension
T4 23-31 gene:2022 denotes endoglin
T5 81-112 disease:C2973725 denotes pulmonary arterial hypertension
T6 23-31 gene:2022 denotes endoglin
T7 81-112 disease:C3714844 denotes pulmonary arterial hypertension
R1 T0 T1 associated_with endoglin,systemic sclerosis
R2 T2 T3 associated_with endoglin,pulmonary arterial hypertension
R3 T4 T5 associated_with endoglin,pulmonary arterial hypertension
R4 T6 T7 associated_with endoglin,pulmonary arterial hypertension

PubmedHPO

Id Subject Object Predicate Lexical cue
T1 156-182 HP_0003549 denotes connective tissue disorder

DisGeNET5_gene_disease

Id Subject Object Predicate Lexical cue
17166870-0#23#31#gene2022 23-31 gene2022 denotes endoglin
17166870-0#54#72#diseaseC0036421 54-72 diseaseC0036421 denotes systemic sclerosis
17166870-0#81#112#diseaseC3203102 81-112 diseaseC3203102 denotes pulmonary arterial hypertension
23#31#gene202254#72#diseaseC0036421 17166870-0#23#31#gene2022 17166870-0#54#72#diseaseC0036421 associated_with endoglin,systemic sclerosis
23#31#gene202281#112#diseaseC3203102 17166870-0#23#31#gene2022 17166870-0#81#112#diseaseC3203102 associated_with endoglin,pulmonary arterial hypertension

tmVarCorpus

Id Subject Object Predicate Lexical cue
T1 503-508 DNAMutation:|INS||6 denotes 6bINS
T2 654-659 DNAMutation:|INS||6 denotes 6bINS
T3 1131-1136 DNAMutation:|INS||6 denotes 6bINS
T4 1430-1435 DNAMutation:|INS||6 denotes 6bINS
T5 1564-1569 DNAMutation:|INS||6 denotes 6bINS